MetLife Investment Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.7K | Sell |
5,932
-122
| -2% | -$1.82K | ﹤0.01% | 2609 |
|
|
2025
Q1 | $70.9K | Hold |
6,054
| – | – | ﹤0.01% | 2643 |
|
|
2024
Q4 | $138K | Hold |
6,054
| – | – | ﹤0.01% | 2477 |
|
|
2024
Q3 | $254K | Buy |
+6,054
| New | +$254K | ﹤0.01% | 2162 |
|
|
2021
Q4 | – | Sell |
-218
| Closed | -$31.6K | – | 2533 |
|
|
2021
Q3 | $31.6K | Sell |
218
-510
| -70% | -$73.8K | ﹤0.01% | 2553 |
|
|
2021
Q2 | $134K | Buy |
728
+537
| +281% | +$99.1K | ﹤0.01% | 2364 |
|
|
2021
Q1 | $47K | Sell |
191
-548
| -74% | -$135K | ﹤0.01% | 2285 |
|
|
2020
Q4 | $208K | Hold |
739
| – | – | ﹤0.01% | 1964 |
|
|
2020
Q3 | $177K | Hold |
739
| – | – | ﹤0.01% | 1931 |
|
|
2020
Q2 | $245K | Buy |
+739
| New | +$245K | ﹤0.01% | 1780 |
|